Breaking News Instant updates and real-time market news.

TEVA

Teva

$16.90

0.02 (0.12%)

10:11
04/09/18
04/09
10:11
04/09/18
10:11

Teva closing Israeli plant after failing to find buyer, Reuters reports

Teva is closing a plant in Israel's Ashdod in March 2019 after failing to find a buyer for the unprofitable facility, Reuters reports. Half of the factory's 175 workers will lose their jobs in the coming months with the rest continuing to work until the plant closes, Teva says. "The Teva Ashdod plant is part of the reorganization process being carried out in Israel and around the world in order to reduce the cost base due to the heavy debt the company faces and the complex business circumstances it is dealing with," Teva said in an emailed statement. Reference Link

  • 18

    May

  • 16

    Jun

TEVA Teva
$16.90

0.02 (0.12%)

02/13/18
WELS
02/13/18
NO CHANGE
WELS
Teva generic comes earlier than expected, says Wells Fargo
Wells Fargo analyst David Maris says Momenta Pharmaceuticals' (MNTA) generic approval of Teva Pharmaceutical's (TEVA) Copaxone came earlier than expected. As recently as the Q4 conference call on February 8, Teva management expected that another generic Copaxone approval would not come until April 2018, Maris tells investors in a research note. The analyst's forecasts assume a continued erosion of Copaxone sales, with sales of $700M in Q1, $500M sales in Q2 and $400M in Q3 and Q4. Maris keeps an Underperform rating on Teva.
02/21/18
DBAB
02/21/18
NO CHANGE
Target $20
DBAB
Hold
Deutsche sees rifamycin as possible long-term threat to Valeant
The outlook for Valeant Pharmaceuticals' (VRX) Xifaxan, which represents 13% of the company's revenue, improved last year following safety issues for competitor Viberzi and delays for generic challenger Teva (TEVA), Deutsche Bank analyst Gregg Gilbert tells investors in a research note. More recently, the analyst notes, questions have been raised as to whether Cosmo's rifamycin could pose a threat to Xifaxan, either in the near term from off-label prescribing for irritable bowel syndrome with diarrhea, or longer term if eventually approved for IBS-D. After due diligence, Gilbert believes rifamycin could potentially be a longer-term threat to Xifaxan if it works for IBS-D, but he does not see "material risk" from off-label use in the interim. His model continues to assume mid-single digit Xifaxan sales growth for several years and a generic cliff in 2025. The analyst keeps a Hold rating on Valeant with a $20 price target.
03/20/18
JEFF
03/20/18
INITIATION
Target $19
JEFF
Hold
Teva resumed with a Hold at Jefferies
Jefferies analyst David Steinberg resumed coverage of Teva Pharmaceutical with a Hold rating and $19 price target. The analyst sees "headwinds on multiple fronts" and believes the positive outlook for Austedo and fremanezumab is priced in with the shares trading at 10 times 2020 consensus EBITDA.
03/26/18
RBCM
03/26/18
NO CHANGE
Target $16
RBCM
Sector Perform
RBC Capital concerned with 'overly ambitious' consensus assumptions for Teva
RBC Capital analyst Randall Stanicky lowered his price target on Teva to $16 from $18, saying that his own model contrasts with "overly optimistic" consensus regarding the P&L assumptions in the company's Branded segment. Specifically, the analyst is concerned with the rising generic competition for Teva's Copaxone as well as fremanezumab, which he expects to miss the June 16 PDUFA "given Celltrion's outstanding Warning Letter" while lowering his peak sales projections by $200M to $1B. Stanicky keeps his Sector Perform rating on Teva, adding that the multi-year turnaround investment thesis on the stock is not supported at this point.

TODAY'S FREE FLY STORIES

01:45
08/14/18
08/14
01:45
08/14/18
01:45
General news
Asian Market Wrap: »

Asian Market Wrap:…

BCE

BCE

$40.57

0.045 (0.11%)

21:57
08/13/18
08/13
21:57
08/13/18
21:57
Upgrade
BCE rating change at Edward Jones »

BCE upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWCH

Switch

$13.96

-0.11 (-0.78%)

21:55
08/13/18
08/13
21:55
08/13/18
21:55
Downgrade
Switch rating change at Raymond James »

Switch downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

FDC

First Data

$23.90

-0.78 (-3.16%)

21:55
08/13/18
08/13
21:55
08/13/18
21:55
Syndicate
First Data 64M share Secondary priced at $23.75 »

Citi acted as lead book…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Sep

  • 14

    Aug

ARDS

Aridis Pharmaceuticals

$0.00

(0.00%)

21:54
08/13/18
08/13
21:54
08/13/18
21:54
Syndicate
Aridis Pharmaceuticals 2M share IPO priced at $13.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

JPM

JPMorgan

$113.88

-1.8 (-1.56%)

20:52
08/13/18
08/13
20:52
08/13/18
20:52
Periodicals
JPMorgan to stop offering investment accounts to foreign clients, Bloomberg says »

JPMorgan will discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

BIIB

Biogen

$340.67

-2.54 (-0.74%)

20:47
08/13/18
08/13
20:47
08/13/18
20:47
Periodicals
UK's NICE: Biogen's Spinraza too expensive for health service, Reuters reports »

U.K.'s National…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

HD

Home Depot

$194.11

-2.19 (-1.12%)

, TPR

Tapestry

$47.42

-0.52 (-1.08%)

20:25
08/13/18
08/13
20:25
08/13/18
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

HD

Home Depot

$194.11

-2.19 (-1.12%)

TPR

Tapestry

$47.42

-0.52 (-1.08%)

AAP

Advance Auto Parts

$144.79

-1.52 (-1.04%)

EAT

Brinker

$43.81

-0.37 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 14

    Aug

  • 12

    Sep

HIL

Hill International

$5.65

(0.00%)

19:45
08/13/18
08/13
19:45
08/13/18
19:45
Hot Stocks
Hill International provides update on NYSE notice of delisting »

Hill Internationa…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Dec

NVDA

Nvidia

$256.08

1.38 (0.54%)

19:36
08/13/18
08/13
19:36
08/13/18
19:36
Hot Stocks
Nvidia launches Turing GPU architecture in computer graphics »

NVIDIA today reinvented…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Aug

ESRX

Express Scripts

$84.04

0.39 (0.47%)

, CI

Cigna

$181.78

-1.59 (-0.87%)

19:33
08/13/18
08/13
19:33
08/13/18
19:33
Hot Stocks
Carl Icahn says will no longer vote against Cigna/Express Scripts deal »

Today Carl Icahn released…

ESRX

Express Scripts

$84.04

0.39 (0.47%)

CI

Cigna

$181.78

-1.59 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 24

    Aug

  • 24

    Aug

MEOH

Methanex

$71.55

-0.45 (-0.63%)

19:17
08/13/18
08/13
19:17
08/13/18
19:17
Hot Stocks
Methanex signs natural gas supply agreement for Chile operations »

Methanex announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PERY

Perry Ellis

$29.10

-0.03 (-0.10%)

19:16
08/13/18
08/13
19:16
08/13/18
19:16
Periodicals
Randa nearing decision on competing Perry Ellis bid, WWD reports »

Randa is in talks with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TCBK

TriCo Bancshares

$39.20

-0.14 (-0.36%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Hot Stocks
TriCo Bancshares names Peter Wiese as CFO, effective August 14 »

TriCo Bancshares…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 07

    Nov

ARQL

ArQule

$5.67

0.21 (3.85%)

, YEXT

Yext

$22.57

-0.18 (-0.79%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Hot Stocks
On The Fly: After Hours Movers »

HIGHER: ArQule (ARQL) up…

ARQL

ArQule

$5.67

0.21 (3.85%)

YEXT

Yext

$22.57

-0.18 (-0.79%)

CWT

California Water Service

$40.05

-0.4 (-0.99%)

SJW

SJW Corp.

$62.49

0.74 (1.20%)

VERI

Veritone

$15.81

1.05 (7.11%)

SWCH

Switch

$13.96

-0.11 (-0.78%)

VIPS

Vipshop

$8.98

-0.15 (-1.64%)

SAIL

SailPoint

$28.39

-0.43 (-1.49%)

RH

RH

$151.63

7.175 (4.97%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 13

    Aug

  • 14

    Aug

  • 04

    Sep

  • 04

    Sep

  • 10

    Sep

  • 16

    Aug

ROSE

Rosehill Resources

$8.36

-0.09 (-1.07%)

19:01
08/13/18
08/13
19:01
08/13/18
19:01
Earnings
Rosehill Resources reports Q2 net income $8.7M vs. loss ($1.4M) last year »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

CMC

Commercial Metals

$21.80

0.11 (0.51%)

18:49
08/13/18
08/13
18:49
08/13/18
18:49
Upgrade
Commercial Metals rating change at Goldman Sachs »

Commercial Metals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Sep

KALU

Kaiser Aluminum

$109.76

-1.35 (-1.22%)

18:44
08/13/18
08/13
18:44
08/13/18
18:44
Downgrade
Kaiser Aluminum rating change at Goldman Sachs »

Kaiser Aluminum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESTA

Establishment Labs

$27.10

0.66 (2.50%)

18:09
08/13/18
08/13
18:09
08/13/18
18:09
Initiation
Establishment Labs initiated at BTIG »

Establishment Labs…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Aug

BRK.A

Berkshire Hathaway

$310,200.00

-1950 (-0.62%)

, BRK.B

Berkshire Hathaway

$205.17

-1.365 (-0.66%)

18:08
08/13/18
08/13
18:08
08/13/18
18:08
Hot Stocks
Berkshire Hathaway comments on quarterly reporting on Form 13F »

"Tomorrow afternoon,…

BRK.A

Berkshire Hathaway

$310,200.00

-1950 (-0.62%)

BRK.B

Berkshire Hathaway

$205.17

-1.365 (-0.66%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PRO

Pros Holdings

$39.80

-0.2 (-0.50%)

18:06
08/13/18
08/13
18:06
08/13/18
18:06
Syndicate
PROS Holdings 450K share Block Trade; price range $7.60-$7.80 »

Barclays is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 14

    Aug

  • 20

    Aug

  • 21

    Aug

  • 16

    Aug

YY

YY

$87.72

-1.09 (-1.23%)

18:06
08/13/18
08/13
18:06
08/13/18
18:06
Earnings
Breaking Earnings news story on YY »

YY sees Q3 revenue growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 10

    Sep

ICUI

ICU Medical

$293.00

0.85 (0.29%)

18:05
08/13/18
08/13
18:05
08/13/18
18:05
Syndicate
ICU Medical 700K share Block Trade; price range $287-$290 »

Barclays is acting as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Aug

YY

YY

$87.72

-1.09 (-1.23%)

18:05
08/13/18
08/13
18:05
08/13/18
18:05
Earnings
YY reports Q2 adjusted EPS $2.03, consensus $1.77 »

Reports Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Aug

  • 10

    Sep

LAC

Lithium Americas

$3.56

-0.17 (-4.56%)

, SQM

SQM

$45.68

-1.16 (-2.48%)

18:03
08/13/18
08/13
18:03
08/13/18
18:03
Hot Stocks
Lithium Americas to partner with Ganfeng Lithium in Cauchari-Olaroz »

Lithium Americas (LAC) is…

LAC

Lithium Americas

$3.56

-0.17 (-4.56%)

SQM

SQM

$45.68

-1.16 (-2.48%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.